Self Assessment of Buccodental Toxicity - Comparison of Patients With Metastatic Renal-cell Carcinoma (RCC) Treated With Sunitinib to Patients Treated With Chemotherapy

被引：0
|
作者：
Gilabert, M. [1 ]
Provansal, M. [1 ]
Cappiello, M. [1 ]
Walz, J. [1 ]
Brunelle, S. [1 ]
Salem, N. [1 ]
Gravis, G. [1 ]
机构：
[1] Inst J Paoli I Calmettes, F-13009 Marseille, France
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72060-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S518 / S518
页数：1
相关论文
共 50 条
  • [31] Re: Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
    van den Meiracker, Anton H.
    Danser, A. H. Jan
    Sleijfer, Stefan
    Kappers, Mariette H. W.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (20) : 1557 - 1557
  • [32] Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
    R J Motzer
    B Escudier
    R Bukowski
    B I Rini
    T E Hutson
    C H Barrios
    X Lin
    K Fly
    E Matczak
    M E Gore
    British Journal of Cancer, 2013, 108 : 2470 - 2477
  • [33] Heterogeneity of Patients With Intermediate-Prognosis Metastatic Renal Cell Carcinoma Treated With Sunitinib
    Sella, Avishay
    Michaelson, M. Dror
    Matczak, Ewa
    Simantov, Ronit
    Lin, Xun
    Figlin, Robert A.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (02) : 291 - 299
  • [34] MiRNAs associated with time to progression in metastatic renal cell carcinoma patients treated with sunitinib
    Merhautova, J.
    Hezova, R.
    Poprach, A.
    Svoboda, M.
    Demlova, R.
    Slaby, O.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S505 - S505
  • [35] Clinical Outcomes for Patients with Metastatic Renal Cell Carcinoma Treated with Alternative Sunitinib Schedules
    Atkinson, Bradley J.
    Kalra, Sarathi
    Wang, Xuemei
    Bathala, Tharakeswara
    Corn, Paul
    Tannir, Nizar M.
    Jonasch, Eric
    JOURNAL OF UROLOGY, 2014, 191 (03): : 611 - 618
  • [36] Olecranon bursitis in patients treated with sunitinib for renal cell carcinoma
    Thomas Gregory
    Olivier Mir
    Jacques Medioni
    Bernard Augereau
    Stéphane Oudard
    Medical Oncology, 2010, 27 : 446 - 448
  • [37] Olecranon bursitis in patients treated with sunitinib for renal cell carcinoma
    Gregory, Thomas
    Mir, Olivier
    Medioni, Jacques
    Augereau, Bernard
    Oudard, Stephane
    MEDICAL ONCOLOGY, 2010, 27 (02) : 446 - 448
  • [38] INTERFERON ALTERNATING WITH CHEMOTHERAPY FOR PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    DEXEUS, FH
    LOGOTHETIS, CJ
    SELLA, A
    FINN, L
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (04): : 350 - 354
  • [39] LIVER TOXICITY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH PAZOPANIB THERAPY
    Lim, F. L.
    Shamash, J.
    Wilson, P.
    Powles, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 290 - 290
  • [40] Liver toxicity in patients with metastatic renal cell carcinoma treated with pazopanib therapy
    Lim, L.
    Mathias, J.
    Lampron, M.
    Fehr, M.
    Gruenwald, V.
    Khan, M.
    Crabb, S.
    Choueiri, T.
    Powles, T.
    Rini, B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S660 - S660
12345